BeStock  
Stocks › Biotechnology › ANAB

AnaptysBio ANAB

US equityMarket cap rank #2932Biotechnology
$46.63 −$0.77 (-1.62%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.63 0.00%
Open$47.49
Prev close$47.40
Day range$46.05 – $47.71
Volume432.5K
Market cap$1.39B
P/E (TTM)9.0
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings8.9x
CheapRich

Near the top of its 5-year range · 93rd percentile, 5-year average -7.8x

#484 of 2992 stocks by PE (1 = cheapest)

Price / book66.1x
CheapRich

Near the top of its 5-year range · 85th percentile, 5-year average 21.4x

#5277 of 5330 stocks by PB (1 = cheapest)

Price / sales5.9x
CheapRich

Near the bottom of its 5-year range · 7th percentile, 5-year average 29.4x

#4103 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-174x-70x34x137xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$42.84
Price vs. fair value+8.8%Trading above the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 66.07 – 21.44 85% (pricier than usual) #5277 of 5330 (1 = cheapest)
PE 8.91 9.54 -7.75 93% (pricier than usual) #484 of 2992 (1 = cheapest)
PS 5.92 11.59 29.45 7% (cheaper than usual) #4103 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ANAB.

Sign in to join the discussion.

Scroll to Top